hotspot -WSS

hotspot

author：fashion 2025-09-27 16:50:23 - browse：1142

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Physician assistants need a new name. Here's what it should be

WSS

American taxpayers paid $1.8 trillion in health care costs in 2022

AstraZeneca stays mum on Medicare drug pricing negotiations

Medicare Advantage plans can’t deny care with AI, CMS warns

A protest over insulin prices is seen as a fight for life

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Problems with a popular proposal to regulate AI in health care

Wikipedia

hotspot

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Surgery pushed Ben Carson to fame

Activists slam private health insurers over coverage restrictions

Problems with a popular proposal to regulate AI in health care

Dobbs anniversary: the lost opportunity of abortion as health care

Male doctors called my cancer incurable. A female doctor showed it wasn't

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cano Health’s bankruptcy is a warning for Medicare Advantage

Novavax promises a turnaround & Lilly roils the obesity market

FDA early review: GLP

hotspot

Johnson & Johnson sued for allegedly overpaying for workers' drugs

What’s missing from the debate over nursing home staff minimums

A single Democrat is willing to weaken Medicare negotiation power

American taxpayers paid $1.8 trillion in health care costs in 2022

Physician assistants need a new name. Here's what it should be

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

knowledge

focus

hotspot

hotspot